A single nucleotide polymorphism in the 3′UTR of the SNCA gene encoding alpha-synuclein is a new potential susceptibility locus for Parkinson disease

Neuroscience Letters

Volumn 461, Issue 2, 2009, Pages 196-201

  Sotiriou, Sotiria ^a   Gibney, Gretchen ^b   Baxevanis, Andreas D ^b   Nussbaum, Robert L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

alpha Synuclein; Parkinson disease; rs17016074; SNCA 3 UTR; SNP

Indexed keywords

ALPHA SYNUCLEIN; LUCIFERASE;

3' UNTRANSLATED REGION; ALLELE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; EXPRESSED SEQUENCE TAG; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE LOCUS; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC COMPLEMENTATION; GENETIC CONSERVATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; POLYADENYLATION; PRIORITY JOURNAL; PROTEIN DOMAIN; REGULATORY SEQUENCE; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

3' UNTRANSLATED REGIONS; ALPHA-SYNUCLEIN; BASE SEQUENCE; CELL LINE, TUMOR; CONSERVED SEQUENCE; EVOLUTION, MOLECULAR; GENES, REPORTER; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MOLECULAR SEQUENCE DATA; PARKINSON DISEASE; POLYADENYLATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, MESSENGER; SEQUENCE ALIGNMENT;

EID: 67649639645     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.06.034     Document Type: Article

References (27)

1. An J.J., Gharami K., Liao G.Y., Woo N.H., Lau A.G., Vanevski F., Torre E.R., Jones K.R., Feng Y., Lu B., and Xu B. Distinct role of long 3′ UTR BDNF mRNA in spine morphology and synaptic plasticity in hippocampal neurons. Cell 134 (2008) 175-187
2. Chartier-Harlin M.C., Kachergus J., Roumier C., Mouroux V., Douay X., Lincoln S., Levecque C., Larvor L., Andrieux J., Hulihan M., Waucquier N., Defebvre L., Amouyel P., Farrer M., and Destee A. alpha-Synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 364 (2004) 1167-1169
3. Chiba-Falek O., Lopez G.J., and Nussbaum R.L. Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients. Mov. Disord. 21 (2006) 1703-1708
4. Chiba-Falek O., and Nussbaum R.L. Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system. Hum. Mol. Genet. 10 (2001) 3101-3109
5. Chou Z.F., Chen F., and Wilusz J. Sequence and position requirements for uridylate-rich downstream elements of polyadenylation signals. Nucleic Acids Res. 22 (1994) 2525-2531
6. Fuchs J., Nilsson C., Kachergus J., Munz M., Larsson E.M., Schule B., Langston J.W., Middleton F.A., Ross O.A., Hulihan M., Gasser T., and Farrer M.J. Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication. Neurology 68 (2007) 916-922
7. Gil A., and Proudfoot N.J. Position-dependent sequence elements downstream of AAUAAA are required for efficient rabbit beta-globin mRNA 3′ end formation. Cell 49 (1987) 399-406
8. Gispert S., Del Turco D., Garrett L., Chen A., Bernard D.J., Hamm-Clement J., Korf H.W., Deller T., Braak H., Auburger G., and Nussbaum R.L. Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation. Mol. Cell Neurosci. 24 (2003) 419-429
9. Grundemann J., Schlaudraff F., Haeckel O., and Liss B. Elevated alpha-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease. Nucleic Acids Res. 36 (2008) e38
10. Hardy J., Cai H., Cookson M.R., Gwinn-Hardy K., and Singleton A. Genetics of Parkinson's disease and parkinsonism. Ann. Neurol. 60 (2006) 389-398
11. Ibanez P., Bonnet A.M., Debarges B., Lohmann E., Tison F., Pollak P., Agid Y., Durr A., and Brice A. Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet 364 (2004) 1169-1171
12. Ikeuchi T., Kakita A., Shiga A., Kasuga K., Kaneko H., Tan C.F., Idezuka J., Wakabayashi K., Onodera O., Iwatsubo T., Nishizawa M., Takahashi H., and Ishikawa A. Patients homozygous and heterozygous for SNCA duplication in a family with parkinsonism and dementia. Arch. Neurol. 65 (2008) 514-519
13. Maraganore D.M., de Andrade M., Elbaz A., Farrer M.J., Ioannidis J.P., Kruger R., Rocca W.A., Schneider N.K., Lesnick T.G., Lincoln S.J., Hulihan M.M., Aasly J.O., Ashizawa T., Chartier-Harlin M.C., Checkoway H., Ferrarese C., Hadjigeorgiou G., Hattori N., Kawakami H., Lambert J.C., Lynch T., Mellick G.D., Papapetropoulos S., Parsian A., Quattrone A., Riess O., Tan E.K., and Van Broeckhoven C. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA 296 (2006) 661-670
14. McLauchlan J., Gaffney D., Whitton J.L., and Clements J.B. The consensus sequence YGTGTTYY located downstream from the AATAAA signal is required for efficient formation of mRNA 3′ termini. Nucleic Acids Res. 13 (1985) 1347-1368
15. Mikulits W., Schranzhofer M., Beug H., and Mullner E.W. Post-transcriptional control via iron-responsive elements: the impact of aberrations in hereditary disease. Mutat. Res. 437 (1999) 219-230
16. Mizuta I., Satake W., Nakabayashi Y., Ito C., Suzuki S., Momose Y., Nagai Y., Oka A., Inoko H., Fukae J., Saito Y., Sawabe M., Murayama S., Yamamoto M., Hattori N., Murata M., and Toda T. Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease. Hum. Mol. Genet. 15 (2006) 1151-1158
17. Mueller J.C., Fuchs J., Hofer A., Zimprich A., Lichtner P., Illig T., Berg D., Wullner U., Meitinger T., and Gasser T. Multiple regions of alpha-synuclein are associated with Parkinson's disease. Ann. Neurol. 57 (2005) 535-541
18. Myhre R., Toft M., Kachergus J., Hulihan M.M., Aasly J.O., Klungland H., and Farrer M.J. Multiple alpha-synuclein gene polymorphisms are associated with Parkinson's disease in a Norwegian population. Acta Neurol. Scand. (2008)
19. Nishioka K., Hayashi S., Farrer M.J., Singleton A.B., Yoshino H., Imai H., Kitami T., Sato K., Kuroda R., Tomiyama H., Mizoguchi K., Murata M., Toda T., Imoto I., Inazawa J., Mizuno Y., and Hattori N. Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease. Ann. Neurol. 59 (2006) 298-309
20. Ouyang M., Case J., Tirunagaru V., and Burnside J. Five hundred sixty-five triples of chicken, human, and mouse candidate orthologs. J. Mol. Evol. 57 (2003) 271-281
21. Rockenstein E., Hansen L.A., Mallory M., Trojanowski J.Q., Galasko D., and Masliah E. Altered expression of the synuclein family mRNA in Lewy body and Alzheimer's disease. Brain Res. 914 (2001) 48-56
22. Ross O.A., Braithwaite A.T., Skipper L.M., Kachergus J., Hulihan M.M., Middleton F.A., Nishioka K., Fuchs J., Gasser T., Maraganore D.M., Adler C.H., Larvor L., Chartier-Harlin M.C., Nilsson C., Langston J.W., Gwinn K., Hattori N., and Farrer M.J. Genomic investigation of alpha-synuclein multiplication and parkinsonism. Ann. Neurol. 63 (2008) 743-750
23. Ross O.A., Gosal D., Stone J.T., Lincoln S.J., Heckman M.G., Irvine G.B., Johnston J.A., Gibson J.M., Farrer M.J., and Lynch T. Familial genes in sporadic disease: common variants of alpha-synuclein gene associate with Parkinson's disease. Mech. Ageing Dev. 128 (2007) 378-382
24. Singleton A.B., Farrer M., Johnson J., Singleton A., Hague S., Kachergus J., Hulihan M., Peuralinna T., Dutra A., Nussbaum R., Lincoln S., Crawley A., Hanson M., Maraganore D., Adler C., Cookson M.R., Muenter M., Baptista M., Miller D., Blancato J., Hardy J., and Gwinn-Hardy K. alpha-Synuclein locus triplication causes Parkinson's disease. Science 302 (2003) 841
25. Tan E.K., Chandran V.R., Fook-Chong S., Shen H., Yew K., Teoh M.L., Yuen Y., and Zhao Y. alpha-Synuclein mRNA expression in sporadic Parkinson's disease. Mov. Disord. 20 (2005) 620-623
26. Waggoner S.A., and Liebhaber S.A. Regulation of alpha-globin mRNA stability. Exp. Biol. Med. (Maywood) 228 (2003) 387-395
27. Winkler S., Hagenah J., Lincoln S., Heckman M., Haugarvoll K., Lohmann-Hedrich K., Kostic V., Farrer M., and Klein C. alpha-Synuclein and Parkinson disease susceptibility. Neurology 69 (2007) 1745-1750